Role of HNF-1α and HNF-1β on insulin, IGF-1 and other potential target genes

References

• Courtois G, Morgan JG, Campbell LA, Fourel G, Crabtree GR. Interaction of a liver-specific nuclear factor with the fibrinogen and α-1-antitrypsin promoters. Science238(4827), 688–692 (1987).
   PubMed Web of Science ®Google Scholar
• Cereghini S, Blumenfeld M, Yaniv M. A liver-specific factor essential for albumin transcription differs between differentiated and dedifferentiated rat hepatoma cells. Genes Dev.2(8), 957–974 (1988).
   PubMed Web of Science ®Google Scholar
• Hardon E, Frain M, Paonessa G, Cortese R. Two distinct factors interact with the promoter regions of several liver-specific genes. EMBO J.7(6), 1711–1719 (1988).
   PubMed Web of Science ®Google Scholar
• Frain M, Swart G, Monaci P et al. The liver-specific transcription factor LF-B1 contains a highly diverged homeobox DNA binding domain. Cell59(1), 145–157 (1989).
   PubMed Web of Science ®Google Scholar
• Cereghini S. Liver-enriched transcription factors and hepatocyte differentiation. FASEB J.10(2), 267–282 (1996).
   PubMed Web of Science ®Google Scholar
• Rey-Campos J, Chouard T, Yaniv M, Cereghini S. vHNF1 is a homeoprotein that activates transcription and forms heterodimers with HNF1. EMBO J.10(6), 1445–1457 (1991).
   PubMed Web of Science ®Google Scholar
• De Simone V, De Magistris L, Lazzaro D et al. LFB3, a heterodimer-forming homeoprotein of the LFB1 family, is expressed in specialized epithelia. EMBO J.10(6), 1435–1443 (1991).
   PubMed Web of Science ®Google Scholar
• Mendel D, Hansen L, Graves M, Conley P, Crabtree G. HNF-1α and HNF-1β (vHNF-1) share dimerization and homeo domains, but not activation domains, and form heterodimers in vitro. Genes Dev.5(6), 1042–1056 (1991).
   PubMed Web of Science ®Google Scholar
• Nicosia A, Monaci P, Tomei L et al. A myosin-like dimerization helix and an extra-large homeodomain are essential elements of the tripartite DNA binding structure of LFB1. Cell61(7), 1225–1236 (1990).
   PubMed Web of Science ®Google Scholar
• Chouard T, Blumenfeld M, Bach I, Vandekerckhove J, Cereghini S, Yaniv M. A distal dimerization domain is essential for DNA-binding by the atypical HNF1 homeodomain. Nucleic Acids Res.18(19), 5853–5863 (1990).
   PubMed Web of Science ®Google Scholar
• Toniatti C, Monaci P, Nicosia A, Cortese R, Ciliberto G. A bipartite activation domain is responsible for the activity of transcription factor HNF1/LFB1 in cells of hepatic and nonhepatic origin. DNA Cell Biol.12(3), 199–208 (1993).
   PubMed Web of Science ®Google Scholar
• Tronche F, Yaniv M. HNF1, a homeoprotein member of the hepatic transcription regulatory network. Bioessays14(9), 579–587 (1992).
   PubMed Web of Science ®Google Scholar
• Mendel D, Khavari P, Conley P et al. Characterization of a cofactor that regulates dimerization of a mammalian homeodomain protein. Science254(5039), 1762–1767 (1991).
   PubMed Web of Science ®Google Scholar
• Soutoglou E, Papafotiou G, Katrakili N, Talianidis I. Transcriptional activation by hepatocyte nuclear factor-1 requires synergism between multiple coactivator proteins. J. Biol. Chem.275(17), 12515–12520 (2000).
   PubMed Web of Science ®Google Scholar
• Ban N, Yamada Y, Someya Y et al. Hepatocyte nuclear factor-1α recruits the transcriptional co-activator p300 on the GLUT2 gene promoter. Diabetes51(5), 1409–1418 (2002).
   PubMed Web of Science ®Google Scholar
• Barbacci E, Chalkiadaki A, Masdeu C et al. HNF1β/TCF2 mutations impair transactivation potential through altered co-regulator recruitment. Hum. Mol. Genet.13(24), 3139–3149 (2004).
   PubMed Web of Science ®Google Scholar
• Kuo C, Conley P, Hsieh C, Francke U, Crabtree G. Molecular cloning, functional expression, and chromosomal localization of mouse hepatocyte nuclear factor 1. Proc. Natl Acad. Sci. USA87(24), 9838–9842 (1990).
   PubMed Web of Science ®Google Scholar
• Ott M, Rey-Campos J, Cereghini S, Yaniv M. vHNF1 is expressed in epithelial cells of distinct embryonic origin during development and precedes HNF1 expression. Mech. Dev.36(1–2), 47–58 (1991).
   PubMed Web of Science ®Google Scholar
• Lazzaro D, De Simone V, De Magistris L, Lehtonen E, Cortese R. LFB1 and LFB3 homeoproteins are sequentially expressed during kidney development. Development114(2), 469–479 (1992).
   PubMed Web of Science ®Google Scholar
• Cereghini S, Ott M, Power S, Maury M. Expression patterns of vHNF1 and HNF1 homeoproteins in early postimplantation embryos suggest distinct and sequential developmental roles. Development116(3), 783–797 (1992).
   PubMed Web of Science ®Google Scholar
• Coffinier C, Barra J, Babinet C, Yaniv M. Expression of the vHNF1/HNF1β homeoprotein gene during mouse organogenesis. Mech. Dev.89(1–2), 211–213 (1999).
   PubMed Web of Science ®Google Scholar
• Haumaitre C, Barbacci E, Jenny M, Ott M, Gradwohl G, Cereghini S. Lack of TCF2/vHNF1 in mice leads to pancreas agenesis. Proc. Natl Acad. Sci. USA102(5), 1490–1495 (2005).
   PubMed Web of Science ®Google Scholar
• Nammo T, Yamagata K, Hamaoka R et al. Expression profile of MODY3/HNF-1α protein in the developing mouse pancreas. Diabetologia45(8), 1142–1153 (2002).
   PubMed Web of Science ®Google Scholar
• Maestro M, Boj S, Luco R et al.Hnf6 and Tcf2 (MODY5) are linked in a gene network operating in a precursor cell domain of the embryonic pancreas. Hum. Mol. Genet.12(24), 3307–3314 (2003).
   PubMed Web of Science ®Google Scholar
• Nammo T, Yamagata K, Tanaka T et al. Expression of HNF-4α (MODY1), HNF-1β (MODY5), and HNF-1α (MODY3) proteins in the developing mouse pancreas. Gene Expr. Patterns8(2), 96–106 (2008).
   PubMed Web of Science ®Google Scholar
• Welters H, Senkel S, Klein-Hitpass L et al. Conditional expression of hepatocyte nuclear factor-1β, the maturity-onset diabetes of the young-5 gene product, influences the viability and functional competence of pancreatic β-cells. J. Endocrinol.190(1), 171–181 (2006).
   PubMed Web of Science ®Google Scholar
• Pontoglio M, Barra J, Hadchouel M et al. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell84(4), 575–585 (1996).
   PubMed Web of Science ®Google Scholar
• Pontoglio M, Sreenan S, Roe M et al. Defective insulin secretion in hepatocyte nuclear factor 1α-deficient mice. J. Clin. Invest.101(10), 2215–2222 (1998).
   PubMed Web of Science ®Google Scholar
• Lee Y, Sauer B, Gonzalez F. Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1α knockout mouse. Mol. Cell. Biol.18(5), 3059–3068 (1998).
   PubMed Web of Science ®Google Scholar
• Shih D, Bussen M, Sehayek E et al. Hepatocyte nuclear factor-1α is an essential regulator of bile acid and plasma cholesterol metabolism. Nat. Genet.27(4), 375–382 (2001).
   PubMed Web of Science ®Google Scholar
• Barbacci E, Reber M, Ott M, Breillat C, Huetz F, Cereghini S. Variant hepatocyte nuclear factor 1 is required for visceral endoderm specification. Development126(21), 4795–4805 (1999).
   PubMed Web of Science ®Google Scholar
• Coffinier C, Thépot D, Babinet C, Yaniv M, Barra J. Essential role for the homeoprotein vHNF1/HNF1β in visceral endoderm differentiation. Development126(21), 4785–4794 (1999).
   PubMed Web of Science ®Google Scholar
• Wang L, Coffinier C, Thomas M et al. Selective deletion of the Hnf1β (MODY5) gene in β-cells leads to altered gene expression and defective insulin release. Endocrinology145(8), 3941–3949 (2004).
   PubMed Web of Science ®Google Scholar
• Coffinier C, Gresh L, Fiette L et al. Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1β. Development129(8), 1829–1838 (2002).
   PubMed Web of Science ®Google Scholar
• Gresh L, Fischer E, Reimann A et al. A transcriptional network in polycystic kidney disease. EMBO J.23(7), 1657–1668 (2004).
   PubMed Web of Science ®Google Scholar
• Sun Z, Hopkins N. vhnf1, the MODY5 and familial GCKD-associated gene, regulates regional specification of the zebrafish gut, pronephros, and hindbrain. Genes Dev.15(23), 3217–3229 (2001).
   PubMed Web of Science ®Google Scholar
• Bagnat M, Cheung I, Mostov K, Stainier D. Genetic control of single lumen formation in the zebrafish gut. Nat. Cell Biol.9(8), 954–960 (2007).
   PubMed Web of Science ®Google Scholar
• Vignali R, Poggi L, Madeddu F, Barsacchi G. HNF1(β) is required for mesoderm induction in the Xenopus embryo. Development127(7), 1455–1465 (2000).
   PubMed Web of Science ®Google Scholar
• Aragón F, Vázquez-Echeverría C, Ulloa E et al. vHnf1 regulates specification of caudal rhombomere identity in the chick hindbrain. Dev. Dyn.234(3), 567–576 (2005).
   PubMed Web of Science ®Google Scholar
• Fajans S, Bell G, Polonsky K. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N. Engl. J. Med.345(13), 971–980 (2001).
   PubMed Web of Science ®Google Scholar
• Ryffel G. Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences. J. Mol. Endocrinol.27(1), 11–29 (2001).
   PubMed Web of Science ®Google Scholar
• Yamagata K, Oda N, Kaisaki P et al. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature384(6608), 455–458 (1996).
   PubMed Web of Science ®Google Scholar
• Horikawa Y, Iwasaki N, Hara M et al. Mutation in hepatocyte nuclear factor-1β gene (TCF2) associated with MODY. Nat. Genet.17(4), 384–385 (1997).
   PubMed Web of Science ®Google Scholar
• Yamagata K, Furuta H, Oda N et al. Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature384(6608), 458–460 (1996).
   PubMed Web of Science ®Google Scholar
• Stoffers D, Zinkin N, Stanojevic V, Clarke W, Habener J. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat. Genet.15(1), 106–110 (1997).
   PubMed Web of Science ®Google Scholar
• Malecki M, Jhala U, Antonellis A et al. Mutations in NEUROD1 are associated with the development of Type 2 diabetes mellitus. Nat. Genet.23(3), 323–328 (1999).
   PubMed Web of Science ®Google Scholar
• Froguel P, Zouali H, Vionnet N et al. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N. Engl. J. Med.328(10), 697–702 (1993).
   PubMed Web of Science ®Google Scholar
• Ellard S, Colclough K. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1α (HNF1α) and 4α (HNF4A) in maturity-onset diabetes of the young. Hum. Mutat.27(9), 854–869 (2006).
   PubMed Web of Science ®Google Scholar
• Byrne M, Sturis J, Menzel S et al. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes45(11), 1503–1510 (1996).
   PubMed Web of Science ®Google Scholar
• Lehto M, Tuomi T, Mahtani M et al. Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect. J. Clin. Invest.9(4), 582–591 (1997).
   Google Scholar
• Frayling T, Evans J, Bulman M et al. β-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes50(Suppl. 1), S94–S100 (2001).
   PubMed Web of Science ®Google Scholar
• Yamada S, Nishigori H, Onda H et al. Identification of mutations in the hepatocyte nuclear factor (HNF)-1α gene in Japanese subjects with IDDM. Diabetes46(10), 1643–1647 (1997).
   PubMed Web of Science ®Google Scholar
• Pearson E, Starkey B, Powell R, Gribble F, Clark P, Hattersley A. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet362(9392), 1275–1281 (2003).
   PubMed Web of Science ®Google Scholar
• Shepherd M, Pearson E, Houghton J, Salt G, Ellard S, Hattersley A. No deterioration in glycemic control in HNF-1α maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas. Diabetes Care26(11), 3191–3192 (2003).
   PubMed Web of Science ®Google Scholar
• Bingham C, Bulman M, Ellard S et al. Mutations in the hepatocyte nuclear factor-1β gene are associated with familial hypoplastic glomerulocystic kidney disease. Am. J. Hum. Genet.68(1), 219–224 (2001).
   PubMed Web of Science ®Google Scholar
• Kolatsi-Joannou M, Bingham C, Ellard S et al. Hepatocyte nuclear factor-1β: a new kindred with renal cysts and diabetes and gene expression in normal human development. J. Am. Soc. Nephrol.12(10), 2175–2180 (2001).
   PubMed Web of Science ®Google Scholar
• Bingham C, Ellard S, Cole T et al. Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-1β mutations. Kidney Int.61(4), 1243–1251 (2002).
   PubMed Web of Science ®Google Scholar
• Bingham C, Ellard S, van’t Hoff W et al. Atypical familial juvenile hyperuricemic nephropathy associated with a hepatocyte nuclear factor-1β gene mutation. Kidney Int.63(5), 1645–1651 (2003).
   PubMed Web of Science ®Google Scholar
• Bingham C, Hattersley A. Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1β. Nephrol. Dial. Transplant.19(11), 2703–2708 (2004).
   PubMed Web of Science ®Google Scholar
• Kitanaka S, Miki Y, Hayashi Y, Igarashi T. Promoter-specific repression of hepatocyte nuclear factor (HNF)-1β and HNF-1α transcriptional activity by an HNF-1β missense mutant associated with Type 5 maturity-onset diabetes of the young with hepatic and biliary manifestations. J. Clin. Endocrinol. Metab.89(3), 1369–1378 (2004).
   PubMed Web of Science ®Google Scholar
• Bellanné-Chantelot C, Chauveau D, Gautier J et al. Clinical spectrum associated with hepatocyte nuclear factor-1β mutations. Ann. Intern. Med.140(7), 510–517 (2004).
   PubMed Web of Science ®Google Scholar
• Edghill E, Bingham C, Ellard S, Hattersley A. Mutations in hepatocyte nuclear factor-1β and their related phenotypes. J. Med. Genet.43(1), 84–90 (2006).
   PubMed Web of Science ®Google Scholar
• Ulinski T, Lescure S, Beaufils S et al. Renal phenotypes related to hepatocyte nuclear factor-1β (TCF2) mutations in a pediatric cohort. J. Am. Soc. Nephrol.17(2), 497–503 (2006).
   PubMed Web of Science ®Google Scholar
• Weber S, Moriniere V, Knüppel T et al. Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: results of the ESCAPE study. J. Am. Soc. Nephrol.17(10), 2864–2870 (2006).
   PubMed Web of Science ®Google Scholar
• Decramer S, Parant O, Beaufils S et al. Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys. J. Am. Soc. Nephrol.18(3), 923–933 (2007).
   PubMed Web of Science ®Google Scholar
• Bellanné-Chantelot C, Clauin S, Chauveau D et al. Large genomic rearrangements in the hepatocyte nuclear factor-1β (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes54(11), 3126–3132 (2005).
   PubMed Web of Science ®Google Scholar
• Edghill E, Bingham C, Slingerland A et al. Hepatocyte nuclear factor-1β mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1β in human pancreatic development. Diabet. Med.23(12), 1301–1306 (2006).
   PubMed Web of Science ®Google Scholar
• Lindner T, Njolstad P, Horikawa Y, Bostad L, Bell G, Sovik O. A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1β. Hum. Mol. Genet.8(11), 2001–2008 (1999).
   PubMed Web of Science ®Google Scholar
• Bingham C, Ellard S, Allen L et al. Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1β. Kidney Int.57(3), 898–907 (2000).
   PubMed Web of Science ®Google Scholar
• Furuta H, Furuta M, Sanke T et al. Nonsense and missense mutations in the human hepatocyte nuclear factor-1β gene (TCF2) and their relation to Type 2 diabetes in Japanese. J. Clin. Endocrinol. Metab.87(8), 3859–3863 (2002).
   PubMed Web of Science ®Google Scholar
• Pearson E, Badman M, Lockwood C et al. Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1α and -1β mutations. Diabetes Care27(5), 1102–1107 (2004).
   PubMed Web of Science ®Google Scholar
• Brackenridge A, Pearson E, Shojaee-Moradie F, Hattersley A, Russell-Jones D, Umpleby A. Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1β and -1α mutations. Diabetes55(2), 405–411 (2006).
   PubMed Web of Science ®Google Scholar
• Haumaitre C, Fabre M, Cormier S, Baumann C, Delezoide A, Cereghini S. Severe pancreas hypoplasia and multicystic renal dysplasia in two human fetuses carrying novel HNF1β/MODY5 mutations. Hum. Mol. Genet.15(15), 2363–2375 (2006).
   PubMed Web of Science ®Google Scholar
• Hattersley A, Pearson E. Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, β-cell physiology, and genetics in diabetes. Endocrinology147(6), 2657–2663 (2006).
   PubMed Web of Science ®Google Scholar
• Wild W, Pogge von Strandmann E, Nastos A et al. The mutated human gene encoding hepatocyte nuclear factor 1β inhibits kidney formation in developing Xenopus embryos. Proc. Natl Acad. Sci. USA97(9), 4695–4700 (2000).
   PubMed Web of Science ®Google Scholar
• Bohn S, Thomas H, Turan G et al. Distinct molecular and morphogenetic properties of mutations in the human HNF1β gene that lead to defective kidney development. J. Am. Soc. Nephrol.14(8), 2033–2041 (2003).
   PubMed Web of Science ®Google Scholar
• Yoshiuchi I, Yamagata K, Zhu Q et al. Identification of a gain-of-function mutation in the HNF-1β gene in a Japanese family with MODY. Diabetologia45(1), 154–155 (2002).
   PubMed Web of Science ®Google Scholar
• Thomas H, Senkel S, Erdmann S et al. Pattern of genes influenced by conditional expression of the transcription factors HNF6, HNF4α and HNF1β in a pancreatic β-cell line. Nucleic Acids Res.32(19), e150 (2004).
   PubMed Web of Science ®Google Scholar
• Kitanaka S, Sato U, Igarashi T. Regulation of human insulin, IGF-I, and multidrug resistance protein 2 promoter activity by hepatocyte nuclear factor (HNF)-1β and HNF-1α and the abnormality of HNF-1β mutants. J. Endocrinol.192(1), 141–147 (2007).
   PubMed Web of Science ®Google Scholar
• Bellanné-Chantelot C, Carette C, Riveline J et al. The type and the position of HNF1α mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3. Diabetes57(2), 503–508 (2008).
   PubMed Web of Science ®Google Scholar
• Edghill E, Oram R, Owens M et al. Hepatocyte nuclear factor-1{β} gene deletions – a common cause of renal disease. Nephrol. Dial. Transplant.23(2), 627–635 (2008).
   PubMed Web of Science ®Google Scholar
• Carette C, Vaury C, Barthélémy A et al. Exonic duplication of the hepatocyte nuclear factor-1β gene (transcription factor 2, hepatic) as a cause of maturity onset diabetes of the young type 5. J. Clin. Endocrinol. Metab.92(7), 2844–2847 (2007).
   PubMed Web of Science ®Google Scholar
• Ellard S, Thomas K, Edghill E et al. Partial and whole gene deletion mutations of the GCK and HNF1α genes in maturity-onset diabetes of the young. Diabetologia50(11), 2313–2317 (2007).
   PubMed Web of Science ®Google Scholar
• Wang H, Maechler P, Hagenfeldt K, Wollheim C. Dominant-negative suppression of HNF-1α function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic β-cell line. EMBO J.17(22), 6701–6713 (1998).
   PubMed Web of Science ®Google Scholar
• Guillam M, Hümmler E, Schaerer E et al. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nat. Genet.17(3), 327–330 (1997).
   PubMed Web of Science ®Google Scholar
• Shih D, Screenan S, Munoz K et al. Loss of HNF-1α function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes50(11), 2472–2480 (2001).
   PubMed Web of Science ®Google Scholar
• Yamagata K, Nammo T, Moriwaki M et al. Overexpression of dominant-negative mutant hepatocyte nuclear factor-1α in pancreatic β-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced β-cell proliferation, and diabetes. Diabetes51(1), 114–123 (2002).
   PubMed Web of Science ®Google Scholar
• Hagenfeldt-Johansson K, Herrera P, Wang H, Gjinovci A, Ishihara H, Wollheim C. β-cell-targeted expression of a dominant-negative hepatocyte nuclear factor-1α induces a maturity-onset diabetes of the young (MODY)3-like phenotype in transgenic mice. Endocrinology142(12), 5311–5320 (2001).
   PubMed Web of Science ®Google Scholar
• Wang H, Antinozzi P, Hagenfeldt K, Maechler P, Wollheim C. Molecular targets of a human HNF1α mutation responsible for pancreatic β-cell dysfunction. EMBO J.19(16), 4257–4264 (2000).
   PubMed Web of Science ®Google Scholar
• Akpinar P, Kuwajima S, Krützfeldt J, Stoffel M. Tmem27: a cleaved and shed plasma membrane protein that stimulates pancreatic β cell proliferation. Cell Metab.2(6), 385–397 (2005).
   PubMed Web of Science ®Google Scholar
• Fukui K, Yang Q, Cao Y et al. The HNF-1 target collectrin controls insulin exocytosis by SNARE complex formation. Cell Metab.2(6), 373–384 (2005).
   PubMed Web of Science ®Google Scholar
• Yamagata K, Nammo T, Sato Y, Saisho K, Shoda H, Fukui K. The HNF-1α–SNARE connection. Diabetes Obes. Metab.9(Suppl. 2), 40–45 (2007).
   PubMed Web of Science ®Google Scholar
• Gu N, Suzuki N, Takeda J et al. Effect of mutations in HNF-1α and HNF-1β on the transcriptional regulation of human sucrase–isomaltase in Caco-2 cells. Biochem. Biophys. Res. Commun.325(1), 308–313 (2004).
   PubMed Web of Science ®Google Scholar
• Gu N, Adachi T, Matsunaga T et al.Mutant HNF-1α and mutant HNF-1β identified in MODY3 and MODY5 downregulate DPP-IV gene expression in Caco-2 cells. Biochem. Biophys. Res. Commun.346(3), 1016–1023 (2006).
   PubMed Web of Science ®Google Scholar
• Senkel S, Lucas B, Klein-Hitpass L, Ryffel G. Identification of target genes of the transcription factor HNF1β and HNF1α in a human embryonic kidney cell line. Biochim. Biophys. Acta1731(3), 179–190 (2005).
   PubMedGoogle Scholar
• Hay C, Docherty K. Comparative analysis of insulin gene promoters: implications for diabetes research. Diabetes55(12), 3201–3213 (2006).
   PubMed Web of Science ®Google Scholar
• Furukawa N, Shirotani T, Nakamaru K, Matsumoto K, Shichiri M, Araki E. Regulation of the insulin gene transcription by glucose. Endocr. J.49(2), 121–130 (2002).
   PubMed Web of Science ®Google Scholar
• Emens L, Landers D, Moss L. Hepatocyte nuclear factor 1α is expressed in a hamster insulinoma line and transactivates the rat insulin I gene. Proc. Natl Acad. Sci. USA89(16), 7300–7304 (1992).
   PubMed Web of Science ®Google Scholar
• Okita K, Yang Q, Yamagata K et al. Human insulin gene is a target gene of hepatocyte nuclear factor-1α (HNF-1α) and HNF-1β. Biochem. Biophys. Res. Commun.263(2), 566–569 (1999).
   PubMed Web of Science ®Google Scholar
• Lee J, Ristow M, Lin X, White M, Magnuson M, Hennighausen L. RIP–Cre revisited, evidence for impairments of pancreatic β-cell function. J. Biol. Chem.281(5), 2649–2653 (2006).
   PubMed Web of Science ®Google Scholar
• Fujimoto K, Sasaki T, Hiki Y et al.In vitro and pathological investigations of MODY5 with the R276X-HNF1β (TCF2) mutation. Endocr. J.54(5), 757–764 (2007).
   PubMed Web of Science ®Google Scholar
• Poll A, Pierreux C, Lokmane L et al. A vHNF1/TCF2-HNF6 cascade regulates the transcription factor network that controls generation of pancreatic precursor cells. Diabetes55(1), 61–69 (2006).
   PubMed Web of Science ®Google Scholar
• Baker J, Liu J, Robertson E, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell75(1), 73–82 (1993).
   PubMed Web of Science ®Google Scholar
• Liu J, Baker J, Perkins A, Robertson E, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell75(1), 59–72 (1993).
   PubMed Web of Science ®Google Scholar
• Woods K, Camacho-Hübner C, Savage M, Clark A. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N. Engl. J. Med.335(18), 1363–1367 (1996).
   PubMed Web of Science ®Google Scholar
• Nakae J, Kido Y, Accili D. Distinct and overlapping functions of insulin and IGF-I receptors. Endocr. Rev.22(6), 818–835 (2001).
   PubMed Web of Science ®Google Scholar
• Nolten L, Steenbergh P, Sussenbach J. Hepatocyte nuclear factor 1α activates promoter 1 of the human insulin-like growth factor I gene via two distinct binding sites. Mol. Endocrinol.9(11), 1488–1499 (1995).
   PubMedGoogle Scholar
• Kulik V, Kavsan V, van Schaik F, Nolten L, Steenbergh P, Sussenbach J. The promoter of the salmon insulin-like growth factor I gene is activated by hepatocyte nuclear factor 1. J. Biol. Chem.270(3), 1068–1073 (1995).
   PubMed Web of Science ®Google Scholar
• Hügl S, White M, Rhodes C. Insulin-like growth factor I (IGF-I)-stimulated pancreatic β-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells. J. Biol. Chem.273(28), 17771–17779 (1998).
   PubMed Web of Science ®Google Scholar
• Guo Y, Lu Y, Houle D et al. Pancreatic islet-specific expression of an insulin-like growth factor-I transgene compensates islet cell growth in growth hormone receptor gene-deficient mice. Endocrinology146(6), 2602–2609 (2005).
   PubMed Web of Science ®Google Scholar
• Yang Q, Yamagata K, Fukui K et al. Hepatocyte nuclear factor-1α modulates pancreatic β-cell growth by regulating the expression of insulin-like growth factor-1 in INS-1 cells. Diabetes51(6), 1785–1792 (2002).
   PubMed Web of Science ®Google Scholar
• Maher J, Slitt A, Callaghan T et al. Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1α. Biochem. Pharmacol.72(4), 512–522 (2006).
   PubMed Web of Science ®Google Scholar
• Kikuchi R, Kusuhara H, Hattori N et al. Regulation of tissue-specific expression of the human and mouse urate transporter 1 gene by hepatocyte nuclear factor 1α/β and DNA methylation. Mol. Pharmacol.72(6), 1619–1625 (2007).
   PubMed Web of Science ®Google Scholar
• Odom D, Zizlsperger N, Gordon D et al. Control of pancreas and liver gene expression by HNF transcription factors. Science303(5662), 1378–1381 (2004).
   PubMed Web of Science ®Google Scholar
• Odom D, Dowell R, Jacobsen E et al. Tissue-specific transcriptional regulation has diverged significantly between human and mouse. Nat. Genet.39(6), 730–732 (2007).
   PubMed Web of Science ®Google Scholar
• Ferrer J. A genetic switch in pancreatic β-cells: implications for differentiation and haploinsufficiency. Diabetes51(8), 2355–2362 (2002).
   PubMed Web of Science ®Google Scholar
• Hiesberger T, Bai Y, Shao X et al. Mutation of hepatocyte nuclear factor-1β inhibits Pkhd1 gene expression and produces renal cysts in mice. J. Clin. Invest.113(6), 814–825 (2004).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wada J, Yasuhara A et al. The role for HNF-1β-targeted collectrin in maintenance of primary cilia and cell polarity in collecting duct cells. PLoS ONE2(5), e414 (2007).
   Google Scholar
• Rebouissou S, Vasiliu V, Thomas C et al. Germline hepatocyte nuclear factor 1α and 1β mutations in renal cell carcinomas. Hum. Mol. Genet.14(5), 603–614 (2005).
   PubMed Web of Science ®Google Scholar
• Ma Z, Gong Y, Patel V et al. Mutations of HNF-1β inhibit epithelial morphogenesis through dysregulation of SOCS-3. Proc. Natl Acad. Sci. USA104(51), 20386–20391 (2007).
   PubMed Web of Science ®Google Scholar
• Iwasaki N, Ogata M, Tomonaga O et al. Liver and kidney function in Japanese patients with maturity-onset diabetes of the young. Diabetes Care21(12), 2144–2148 (1998).
   PubMed Web of Science ®Google Scholar
• Montoli A, Colussi G, Massa O et al. Renal cysts and diabetes syndrome linked to mutations of the hepatocyte nuclear factor-1β gene: description of a new family with associated liver involvement. Am. J. Kidney Dis.40(2), 397–402 (2002).
   PubMed Web of Science ®Google Scholar
• Beckers D, Bellanné-Chantelot C, Maes M. Neonatal cholestatic jaundice as the first symptom of a mutation in the hepatocyte nuclear factor-1β gene (HNF-1β). J. Pediatr.150(3), 313–314 (2007).
   PubMed Web of Science ®Google Scholar
• Boudreau F, Zhu Y, Traber P. Sucrase-isomaltase gene transcription requires the hepatocyte nuclear factor-1 (HNF-1) regulatory element and is regulated by the ratio of HNF-1α to HNF-1β. J. Biol. Chem.276(34), 32122–32128 (2001).
   PubMed Web of Science ®Google Scholar
• Song Y, Ray K, Liebhaber S, Cooke N. Vitamin D-binding protein gene transcription is regulated by the relative abundance of hepatocyte nuclear factors 1α and 1β. J. Biol. Chem.273(43), 28408–28418 (1998).
   PubMed Web of Science ®Google Scholar
• Párrizas M, Maestro M, Boj S et al. Hepatic nuclear factor 1-α directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets. Mol. Cell. Biol.21(9), 3234–3243 (2001).
   PubMed Web of Science ®Google Scholar
• Luco R, Maestro M, del Pozo N, Philbrick W, de la Ossa P, Ferrer J. A conditional model reveals that induction of hepatocyte nuclear factor-1α in Hnf1α-null mutant β-cells can activate silenced genes postnatally, whereas overexpression is deleterious. Diabetes55(8), 2202–2211 (2006).
   PubMed Web of Science ®Google Scholar
• Winckler W, Burtt N, Holmkvist J et al. Association of common variation in the HNF1α gene region with risk of Type 2 diabetes. Diabetes54(8), 2336–2342 (2005).
   PubMed Web of Science ®Google Scholar
• Weedon M, Owen K, Shields B et al. A large-scale association analysis of common variation of the HNF1α gene with Type 2 diabetes in the U.K. Caucasian population. Diabetes54(8), 2487–2491 (2005).
   PubMed Web of Science ®Google Scholar
• Gudmundsson J, Sulem P, Rafnar T et al. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat. Genet.40(3), 281–283 (2008).
   PubMed Web of Science ®Google Scholar
• Furihata T, Satoh T, Yamamoto N, Kobayashi K, Chiba K. Hepatocyte nuclear factor 1α is a factor responsible for the interindividual variation of OATP1β1 mRNA levels in adult Japanese livers. Pharm. Res.24(12), 2327–2332 (2007).
   PubMed Web of Science ®Google Scholar
• Bluteau O, Jeannot E, Bioulac-Sage P et al. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat. Genet.32(2), 312–315 (2002).
   PubMed Web of Science ®Google Scholar
• Terasawa K, Toyota M, Sagae S et al. Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines. Br. J. Cancer94(6), 914–921 (2006).
   PubMed Web of Science ®Google Scholar
• Fischer E, Legue E, Doyen A et al. Defective planar cell polarity in polycystic kidney disease. Nat. Genet.38(1), 21–23 (2006).
   PubMed Web of Science ®Google Scholar
• Boj S, Parrizas M, Maestro M, Ferrer J. A transcription factor regulatory circuit in differentiated pancreatic cells. Proc. Natl Acad. Sci. USA98(25), 14481–14486 (2001).
   PubMed Web of Science ®Google Scholar
• Hansen S, Párrizas M, Jensen M et al. Genetic evidence that HNF-1α-dependent transcriptional control of HNF-4α is essential for human pancreatic β cell function. J. Clin. Invest.110(6), 827–833 (2002).
   PubMed Web of Science ®Google Scholar
• Thomas H, Jaschkowitz K, Bulman M et al. A distant upstream promoter of the HNF-4α gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum. Mol. Genet.10(19), 2089–2097 (2001).
   PubMed Web of Science ®Google Scholar